Pluri (NASDAQ:PLUR) Posts Quarterly Earnings Results

Pluri (NASDAQ:PLURGet Free Report) issued its earnings results on Tuesday. The company reported ($0.53) earnings per share (EPS) for the quarter, Zacks reports. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

Pluri Trading Up 0.7 %

Shares of Pluri stock traded up $0.03 on Tuesday, hitting $4.33. The stock had a trading volume of 4,142 shares, compared to its average volume of 13,152. The company has a quick ratio of 5.90, a current ratio of 5.90 and a debt-to-equity ratio of 4.44. Pluri has a one year low of $4.07 and a one year high of $8.48. The stock has a market cap of $24.07 million, a price-to-earnings ratio of -0.72 and a beta of 1.67. The stock’s 50-day simple moving average is $4.53 and its two-hundred day simple moving average is $4.99.

Pluri Company Profile

(Get Free Report)

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.

See Also

Earnings History for Pluri (NASDAQ:PLUR)

Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.